Oliver Severn
GENERAL
Singer Instruments was established in 1934 and has a long-standing track record developing and manufacturing mechatronic workstations and laboratory automation robotics. Our world-leading, specialist products are used to facilitate and accelerate genetic and genomic research around the world. We supply public and private research institutions in multiple facets of biological sciences including Genetics, Neuroscience, Systems Biology, Cancer Biology, Biofuel Engineering and microbiology.
ROLE
Dr Harry Singer, Managing Director, 100% FTE, key stakeholder for the project Dr Oliver Severn, Internal Principal Investigator, 100% FTE, will line-manage, including research, training and supervision. Dr Chong Da, Consultant Scientist and Asia Oceania Business Manager, 100% FTE Dr Nripesh Dhungel, Consultant Scientist and North America Business Manager, 100% FTE.
PROJECTS
-
Quantification of vitality in novel heterozygotes S. cerevisiae industrial strains